Evidence map›Paper›PMID 32154392›Full record

ArticleClinical and translational radiation oncology2020

Nodal recurrence patterns on PET/CT after RTOG-based nodal radiotherapy for prostate cancer.

C P Liskamp, M L Donswijk, H G van der Poel, E E Schaake, W V Vogel

Open access · goldAbstract read
In one paragraph

Article in Clinical and translational radiation oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

C P LiskampDepartment of Radiation Oncology, NKI-AVL, Amsterdam, The Netherlands.
M L DonswijkDepartment of Nuclear Medicine, NKI-AVL, Amsterdam, The Netherlands.
H G van der PoelDepartment of Urology, NKI-AVL, Amsterdam, The Netherlands.
E E SchaakeDepartment of Radiation Oncology, NKI-AVL, Amsterdam, The Netherlands.
W V VogelDepartment of Radiation Oncology, NKI-AVL, Amsterdam, The Netherlands.
The Netherlands Cancer Institute · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeBiochemical failure after external beam radiotherapy (RT) for node-positive prostate cancer (PC METHODS AND MATERIALS: Data of all patients treated with curative intent EBRT for PC

results42 patients received PSMA (28) or choline (14) PET/CT at biochemical recurrence. 35 patients (83%) had a positive scan. At their first positive scan 17 patients had nodal metastasis, in some cases together with a local recurrence or distant disease. In-field nodal recurrences were uncommon (n = 3). Out-field nodal recurrences occurred more frequently (n = 14), with the majority (n = 12) just above the elective nodal field. These nodes were the single area of detectable failure in 6 patients (14%).

conclusionsCurrent RT with RTOG-based nodal fields for PC

Indexed as

BCR, biochemical recurrenceCholine PET/CTePLND, extended pelvic lymph node dissectionGS, Gleason ScoreIMRT, Intensity-Modulated Radiation TherapyIRB, Institutional Review BoardLND, Lymph Node DissectionNKI-AVL, Nederlands Kanker Instituut Antoni van LeeuwenhoekPCN+, node-positive prostate cancerPET/CT, positron emission tomography / computed tomographyProstate cancerPSMA PET/CTPSMA, Prostate-Specific Membrane AntigenRadiotherapyRecurrence patternsrLND, retroperitoneal lymph node dissection (rLND)RP, radical prostatectomyRT, external beam radiotherapyRTOG, Radiation Therapy Oncology GroupSNB, Sentinel Node BiopsySNP, Sentinel Node ProceduresRT, Salvage RadiotherapyTarget definitionVMAT, Volumetric Arc Therapy

Identifiers

PMID32154392
PMCPMC7056599
OpenAlexW3008640298

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.